In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...
Brock did, in fact, find bacteria reproducing inside the hot springs — a discovery critical to the development of polymerase chain reaction, a DNA sequencing method that has advanced biotech, ...
INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...
According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...
Genetix Biotherapeutics Inc. today announced that an analysis of recent patient experience data from the commercial implementation of LYFGENIAtm and ZYNTEGLOtm in the U.S. has been selected for oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback